Quaternary Ammonium Containing Patents (Class 514/642)
  • Publication number: 20120177712
    Abstract: This invention relates to a bipolar antimicrobial particle for use in laundry detergent compositions, fabric conditioners, personal care and cosmetic compositions and a process for making the same. In view of the foregoing, it is an object of the present invention to provide a stabile antimicrobial agent immobilised on a carrier particle. It is a further objective to provide an antimicrobial particle with improved retention to the fabric so that larger amounts of antimicrobial will be available even after rinsing. Surprisingly it has been found that antimicrobial molecules tagged by surface reaction onto naturally occurring asymmetric clay surfaces, act as an antimicrobial particle with improved retention properties with improved stability.
    Type: Application
    Filed: August 30, 2010
    Publication date: July 12, 2012
    Inventors: Arpita Bhattacharya, Sudipta Ghosh Dastidar, Vidula Iyer, Suresh Sambamurthy Jayaraman, Maya Treesa Saji
  • Patent number: 8217081
    Abstract: A polymerizable biomedical composition includes a quaternary ammonium group bonded at its quaternary sites to respective groups R1, R2, R3, and R4. R1 and R2 each include a vinyl moiety such that the composition is at least bi-functional with respect to polymerization.
    Type: Grant
    Filed: December 28, 2009
    Date of Patent: July 10, 2012
    Assignee: The United States of America as represented by the Secretary of Commerce, The National Institute of Standards and Technology
    Inventor: Joseph M. Antonucci
  • Patent number: 8211453
    Abstract: The present invention relates to antibacterial composition containing silver complexes, antibacterial treatment methods using the same and antibacterial formed article, in which the antibacterial composition containing silver complexes is economical, not wearing off due to washing, cleaning, rubbing, etc., firmly combined to improve durability and antibacterial effect, and applicable to various products due to great solubility and stability.
    Type: Grant
    Filed: March 14, 2007
    Date of Patent: July 3, 2012
    Assignee: Inktec Co., Ltd.
    Inventors: Kwang-Choon Chung, Hyun-Nam Cho, Eun-Jin Park, Young-Kwan Seo, Ju-Jin Choi, Dong-Lib Kim, Hyoung-Seok Kim
  • Patent number: 8193240
    Abstract: Compositions useful for weight management in an animal are disclosed. The compositions comprise one or more isoflavones or isoflavone metabolites, and in some embodiments include conjugated linoleic acid, and/or L-carnitine. Also disclosed are methods useful for weight management in an animal utilizing compositions comprising one or more isoflavones, conjugated linoleic acid, and/or L-carnitine. Preferably, the compositions and methods employ a combination of one or more isoflavones, or a combination of one or more isoflavones in conjunction with conjugated linoleic acid, and L-carnitine.
    Type: Grant
    Filed: March 17, 2005
    Date of Patent: June 5, 2012
    Assignee: Nestec S.A.
    Inventor: Yuanlong Pan
  • Publication number: 20120114728
    Abstract: A biodelivery system has been found which increases the efficiency and effectiveness of introducing antimicrobial compounds into complex biofilm matrices through the use of liposome carriers, thereby removing the biofouling in industrial water bearing systems, including piping, heat exchanges, condensers, filtration systems and fluid storage tanks. According to one embodiment of the invention, antimicrobial compound containing liposomes are added to water systems prone to biofouling and biofilm formation. The liposomes, being similar in composition to microbial membranes or cells, are readily incorporated into the existing biofilm. Once the antimicrobial compound containing liposomes become entrained with the biofilm matrix, the decomposition or disintegration of the liposome proceeds. Thereafter the biocidal core is released to react directly with the biofilm encased microorganisms.
    Type: Application
    Filed: February 12, 2010
    Publication date: May 10, 2012
    Inventors: Wilson Kurt Whitekettle, Gloria Jean Tafel, Kimberly Murphy, Qing Zhao
  • Publication number: 20120107415
    Abstract: The invention relates to a novel combined disinfection and decontamination agent comprising at least one vitamin, at least one metal ion, at least one active-surface compound, and at least one further antimicrobial active substance. The agent according to the invention surprisingly shows nearly complete nucleic acid disintegration in addition to an improved disinfectant effect. The agent can be successfully used as a combined decontamination and disinfection agent for skin, mucous membranes, hands, wounds, and/or hair, and instruments and surfaces of all kinds.
    Type: Application
    Filed: November 14, 2009
    Publication date: May 3, 2012
    Inventors: Thomas Lisowsky, Sven Eggerstedt, Richard Bloss, Christiane Ostermeyer, Karlheinz Esser, Frank Bürger, Barbara Krug, Yvonne Feil, Kai-Martin Mueller, Delphine Haase
  • Publication number: 20120107300
    Abstract: Cannabinoid compositions and methods of administering said cannabinoid compositions are disclosed. The cannabinoid compositions disclosed herein include compounds which have been strategically selected to eliminate, or least mitigate, one of the negative side effects associated with consuming cannabinoids. A daytime formula includes compounds aimed at nullifying the negative side effects that cannabinoid consumption has on a patient's daily operations and activities. A nighttime formula includes compounds aimed at nullifying the negative side effects that cannabinoid consumption has a patient's sleep.
    Type: Application
    Filed: November 1, 2010
    Publication date: May 3, 2012
    Inventor: Jeffrey Nathan Schirripa
  • Patent number: 8158827
    Abstract: Disclosed are cationic lipid compounds and compositions of lipid aggregates for delivery of macromolecules and other compounds into cells. The compounds can be used alone or in combination with other compounds to prepare liposomes and other lipid aggregates suitable for transfection or delivery of compounds to target cells, either in vitro or in vivo. The compounds are preferably polycationic and preferably form highly stable complexes with various anionic macromolecules, particularly polyanions such as nucleic acids. These compounds have the property, when dispersed in water, of forming lipid aggregates which associate strongly, via their cationic portion, with polyanions. Also disclosed are intermediates for preparing the compound and compositions of the invention and methods of using the compounds to introduce other compounds into cells.
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: April 17, 2012
    Assignee: Life Technologies Corporation
    Inventors: Yongliang Chu, Malek Masoud, Gulilat Gebeyehu
  • Publication number: 20120077880
    Abstract: The invention relates to highly concentrated, spherical, biopolymer gel particle suspensions comprising particle of defined particle diameter range (e.g., 1 to 50?) and process for preparing the suspensions utilizing high internal phase emulsion as intermediate.
    Type: Application
    Filed: September 24, 2010
    Publication date: March 29, 2012
    Applicant: CONOPCO, INC., D/B/A UNILEVER
    Inventors: Congling Quan, Teanoosh Moaddel, Badreddine Ahtchi-Ali
  • Publication number: 20120077881
    Abstract: The invention relates to process for making highly concentrated, spherical biopolymer gel particle suspensions comprising particles of defined particle diameter (e.g., range of 1 to 50?) utilizing high internal phase emulsion as an intermediate.
    Type: Application
    Filed: September 24, 2010
    Publication date: March 29, 2012
    Applicant: CONOPCO, INC., D/B/A UNILEVER
    Inventors: Congling Quan, Teanoosh Moaddel, Badreddine Ahtchi-Ali
  • Patent number: 8143314
    Abstract: Pharmaceutical compositions and methods for treating ineffective esophageal motility in which bethanechol and pharmaceutically acceptable absorption enhancers comprising bile acids and mixtures thereof are topically introduced to the esophagus. Therapeutically effective amounts of bethanechol are delivered while reducing or eliminating parasympathetic nervous system side effects normally associated with systemic bethanechol delivery.
    Type: Grant
    Filed: September 15, 2008
    Date of Patent: March 27, 2012
    Inventor: Robert Carl Stover
  • Publication number: 20120071525
    Abstract: The present invention provides an anti-microbial composition comprising (i) an antimicrobial agent with surfactant properties, (ii) a siloxane selected from those having the formulae V:(H3C)[SiO(CH3)2]nSi(CH3)3, and (H3C)[SiO(CH3)HnSi(CH3)3, and mixtures thereof, wherein n is from 1 to 24; and (iii) a polar solvent, wherein the ratio of (i) to (ii) is from about 100:1 to about 5:1.
    Type: Application
    Filed: October 26, 2011
    Publication date: March 22, 2012
    Applicant: BYOTROL PLC
    Inventors: Ulrich Schwarz, Stephen Brian Falder
  • Publication number: 20120070341
    Abstract: The antimicrobial composition of the present invention comprises a cationic active ingredient, a quaternized sugar-derived surfactant, and an optional foam boosting surfactant. The present antimicrobial compositions are free of the antimicrobial agent triclosan (i.e., 2,4,4?-trichloro-2?hydroxy-diphenylether), have a high cidal activity in a short amount of time, provide stable copious foam and exhibit enhanced tissue (e.g. skin) compatibility as defined by an in vitro whole toxicology assessment method.
    Type: Application
    Filed: September 21, 2011
    Publication date: March 22, 2012
    Applicant: ECOLAB USA INC.
    Inventors: Angela R. Eder, Daniel E. Pedersen, Charles A. Hodge
  • Publication number: 20120071438
    Abstract: The antimicrobial composition of the present invention comprises a cationic active ingredient, a quaternized sugar-derived surfactant, and an optional foam boosting surfactant. These formulations have a high cidal activity in a short amount of time and provide stable copious foam. The formulations of the present invention also exhibit enhanced tissue (e.g. skin) compatibility as defined by an in vitro whole toxicology assessment method.
    Type: Application
    Filed: September 21, 2011
    Publication date: March 22, 2012
    Applicant: ECOLAB USA INC.
    Inventors: Daniel E. Pedersen, Angela R. Eder, Charles A. Hodge
  • Publication number: 20120071521
    Abstract: A concentrated quaternary ammonium compound (QAC) solution comprising a QAC with a concentration greater than about 10% by weight and at least one solubility enhancing agent, such as an alcohol, is disclosed. A diluted QAC solution is useful on food products to prevent microbial growth on the food from a broad spectrum of foodborne microbial contamination. Also disclosed is a method of contacting food products with the dilute QAC for an application time of at least 0.1 second. Foods that can be treated by this method are meat and meat products, seafood, vegetables, fruit, dairy products, pet foods and snacks, and any other food that can be 10 treated and still retain its appearance and texture. One of the treatment methods is spraying and misting the QAC solutions on the food products for an application time of at least 0.1 second to prevent broad spectrum foodborne microbial contamination.
    Type: Application
    Filed: November 4, 2011
    Publication date: March 22, 2012
    Inventors: Cesar COMPADRE, Philip Breen, Hamid Salari, E. Kim Fifer, Danny L. Lattin, Michael Slavik, Yanbin Li, Timothy O'Brien, Amy L. Waldroup, Thomas F. Berg
  • Patent number: 8138156
    Abstract: Ophthalmic composition comprising one or more polyglycines selected from the group consisting of diglycine, triglycine, tetraglycine and pentaglycine, or the salts of each thereof and one or more boron buffering compounds. The ophthalmic composition will have an osmolality of from 200 mOsmol/kg to 420 mOsmol/kg.
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: March 20, 2012
    Assignee: Bausch & Lomb Incorporated
    Inventors: Susan E. Burke, Erning Xia, Catherine Scheuer, Srini Venkastesh
  • Publication number: 20120040831
    Abstract: Embodiments of the present invention disclose an agricultural composition that is a field ready spray or a tank mix that includes at least one nitrogen containing isethionic acid salt, at least one agriculturally active ingredient, and at least one surfactant.
    Type: Application
    Filed: April 23, 2010
    Publication date: February 16, 2012
    Applicant: Huntsman Petrochemical LLC
    Inventors: R. Scott Tann, Howard M. Stridde
  • Publication number: 20120034290
    Abstract: The present invention relates to quaternary ammonium salts and their use as mold inhibitors. The quaternary salts can be prepared by a chloride ion-promoted reaction between a tertiary amine and an alcohol or polyol in strong acid solution. The quaternary ammonium salts can be applied to a substrate in order to impart anti-mold properties to the substrate. Preferably, the quaternary ammonium salt compounds are applied to paper substrates in an amount of about 1000 ppm. Preferably, the quaternary ammonium salts compounds are applied as mixtures of more than one quaternary ammonium salt compound. The treated substrate does not require encapsulators, binders, or retention aids.
    Type: Application
    Filed: August 29, 2007
    Publication date: February 9, 2012
    Inventors: Maurice C. Kemp, David E. Lewis
  • Publication number: 20120034287
    Abstract: A nonwoven absorbent wipe is impregnated with an antibacterial and antimicrobial composition comprising quaternary ammonium salts, glycol ethers, a surfactant and water. A method of preparation and a process for disinfecting hard surfaces with the wipe are provided.
    Type: Application
    Filed: August 3, 2010
    Publication date: February 9, 2012
    Inventors: Lisa A. Napolitano, Michael V. Monticello, Roy Blank, Gabriel Odame
  • Publication number: 20120034313
    Abstract: A chemical blend that simultaneously kills bacteria and suppresses the production of hydrogen sulfide (H2S) includes both a first chemical, which may be a glutaraldehyde, a tetrakishydroxymethyl phosphonium sulfate (THPS), a quaternary amine compound, a thiocyanate, a carbamate, a cinnamaldehyde, an alkyl dimethyl benzyl ammonium chloride, and/or a diamine diacetate; a second chemical which is a quinone; optionally a third chemical, which is a phosphate compound and a solvent which includes monoethylene glycol. The chemical blend has shown synergistic results for killing bacteria and/or suppressing the production of hydrogen sulfide as compared with the addition of the results of each of the components of the blend used separately.
    Type: Application
    Filed: March 15, 2011
    Publication date: February 9, 2012
    Applicant: Baker Hughes Incorporated
    Inventors: Jodi Beth Wrangham, Sebastian D. Mancuso
  • Patent number: 8106151
    Abstract: A ophthalmic composition, comprising: an aqueous liquid medium, and an effective amount of polyquaternium-1 made by a process of: a) mixing 1,4-bis-dimethylamino-2-butene, triethanolamine and an acid; b) introducing a 1,4-dichloro-2-butene to the mixture, and c) isolating polyquaternium-1 having a molecular weight as determined by a proton NMR method of about 10,000 or more, at a yield of at least about 50%.
    Type: Grant
    Filed: January 25, 2010
    Date of Patent: January 31, 2012
    Assignee: Abbot Medical Optics Inc.
    Inventor: Zhi-Jian Yu
  • Patent number: 8097752
    Abstract: Disclosed are novel ring containing phospholipids represented by the structural formula A-X—PO3—W and physiologically acceptable salts thereof and a process for the preparation of these compounds. The compounds can be used for the treatment of protozoal diseases and especially leishmaniasis.
    Type: Grant
    Filed: October 29, 2003
    Date of Patent: January 17, 2012
    Assignee: MAKScientific, LLC
    Inventors: Theodora Calogeropoulou, Maria Koufaki, Nikolaos Avlonitis, Alexandros Makriyannis
  • Publication number: 20110319790
    Abstract: Provided is a pharmaceutical composition for permeabilizing fetal membranes including an active ingredient having a log K in the range of 2 to 4, where K is the octanol/water partition coefficient. The active ingredient may be, for example, bupivacaine, sodium lauryl sulfate or oleic acid. Further provided is a system for transfetal membrane transport. The system includes a probe unit adapted for insertion into a female reproductive tract and releasing a substance onto fetal membranes that permeabilizes the membranes. The system is also configured to apply ultrasound radiation to the fetal membranes to further increase the membrane permeability.
    Type: Application
    Filed: November 25, 2009
    Publication date: December 29, 2011
    Applicant: B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD.
    Inventors: Joseph Kost, Mordechai Halak, Drora Shmilovitch, Tamar Triatel, Rivka Goldbart, Aharon Azaguri, Lior Wollach
  • Publication number: 20110313049
    Abstract: Antibacterial compositions having antibacterial effectiveness and reduced eye irritation potential are disclosed. The antibacterial compositions contain a quaternary ammonium compound, an alkamine oxide, a nonionic compound, optional adjuvant materials known in the art, and water. The eye irritation is decreased by decreasing the amount, by weight, of alkamine oxide present in the composition and alternatively, or in combination therewith, increasing the ratio of nonionic material to alkamine oxide present in the composition.
    Type: Application
    Filed: August 25, 2011
    Publication date: December 22, 2011
    Applicant: The Dial Corporation
    Inventors: Timothy J. Taylor, Priscilla S. Fox, Kathleen Carmelle Cater
  • Publication number: 20110293681
    Abstract: The present invention provides for topical adhesive patch that includes a backing having a front side and a back side; a formulation in contact with the front side of the backing, the formulation including an adhesive; and at least one antimicrobial. The antimicrobial is integrally bonded to the back side of the backing. The present invention also provides for a method of reducing the number of microbes located upon a topical skin surface of a mammal, as well as a method of preventing the transmission of a communicable disease capable of being transmitted by physical contact. The methods include topically contacting a skin surface of the mammal with the back side of the topical adhesive patch.
    Type: Application
    Filed: February 25, 2011
    Publication date: December 1, 2011
    Applicant: LecTec Corporation
    Inventors: Judd Berlin, Daniel Sigg
  • Publication number: 20110287083
    Abstract: Bioabsorbable compositions of A) blends of bioabsorbable homopolymers and/or copolymers containing glycolide and lactide and B) salts of fatty acids and/or fatty acid esters are described. Processes for making the compositions and surgical articles made totally or in part therefrom, including suture coatings, are also described.
    Type: Application
    Filed: July 21, 2011
    Publication date: November 24, 2011
    Applicant: Tyco Healthcare Group LP
    Inventor: Ahmad R. Hadba
  • Publication number: 20110263665
    Abstract: The present invention describes a formulation comprising: (A) at least one surfactant; and (B) an anti-microbial composition that comprises (i) an anti-microbial agent with surfactant properties; (ii) a hydrophobic material and (iii) a polar solvent.
    Type: Application
    Filed: July 5, 2011
    Publication date: October 27, 2011
    Applicant: BYOTROL PLC
    Inventors: Ulrich Schwarz, Stephen Brian Falder, John Yates
  • Publication number: 20110257109
    Abstract: The present invention encompasses compositions and methods that activate P2Y receptors for the increased production of new synapses in the central nervous system. The formulations of the invention may be administered to a healthy subject or to a subject in need thereof to restore synapses.
    Type: Application
    Filed: April 19, 2011
    Publication date: October 20, 2011
    Inventor: Richard WURTMAN
  • Publication number: 20110256510
    Abstract: Disclosed are compositions and methods of using such compositions for inhibiting matrix metalloproteinase activity in dental tissue. The compositions, methods and uses may prevent degradation of the bonding between restorative materials and dental tissues, thereby increasing durability and longevity of the restorative material-dental tissue bonds. For example, the compositions, methods, and uses of the present invention may be used for treating carious dental tissue such as by the creation of dental fillings, crowns, bridges, among other techniques, as well as the creation of esthetic laminate restorations.
    Type: Application
    Filed: January 11, 2010
    Publication date: October 20, 2011
    Inventors: David Henry Pashley, Franklin Chin-Meng Tay, Milena Cadenaro
  • Publication number: 20110250286
    Abstract: A system for the controlled release of one or more physiologically or pharmacologically active substances, comprising compositions in the form of micro particles or granules, particularly for use in the zootechnical and/or veterinary field. The micro particles include a core which contains one or more substances having a pharmacological action, food supplements or diagnostic media, said one or more substances being characterized by the presence, within their chemical structure, of a basic functional group, specifically including an amine functional group. The core comprises also one or more carboxylic acids and/or their salts and eventually one or more excipients. Said core is coated by an outer layer of fats or waxes, and preferably by a mixture of glyceride of fatty acids.
    Type: Application
    Filed: April 7, 2011
    Publication date: October 13, 2011
    Applicant: KEMIN INDUSTRIES, INC.
    Inventors: Arduini Marcello, Arduini Lauro
  • Patent number: 8034977
    Abstract: Cationic lipid compositions are provided that are useful for efficient delivery of macromolecules, such as nucleic acids, into a wide variety of eukaryotic cell types. Methods for using the compositions also are provided.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: October 11, 2011
    Assignee: Molecular Transfer, Inc.
    Inventors: Gulilat Gebeyehu, Taysir M. Jaouni, Joel Jessee
  • Publication number: 20110245348
    Abstract: The method of treating type I diabetes includes the treatment of diabetic patients with choline in order to control the patient's lipid profile. The treatment method includes the step of administering to the patient a therapeutically effective dosage of choline or a pharmaceutically acceptable salt thereof. In human patients, the effective dosage of choline is preferably approximately 10 mg., delivered daily. Although the choline may be injected in solution, it is preferably delivered orally to the patient.
    Type: Application
    Filed: April 6, 2010
    Publication date: October 6, 2011
    Inventor: Fatma Jassab Faleh Marzooq Al-Saeedi
  • Patent number: 8025892
    Abstract: Gel particles or beads can be prepared by forming a hot aqueous solution of a gelling agent, and discharging the hot gelling agent solution through a discharge orifice into a cold moving stream of hydrophobic liquid so that the gelling agent solution cools rapidly and good quality gel particles coalesce in the cold hydrophobic liquid stream. The cold hydrophobic liquid stream can be contained in a conduit so that the cold hydrophobic liquid stream moves past the discharge orifice and exerts a force on hot solution in the discharge orifice, the force acting to withdraw the hot solution from the discharge orifice. Optionally, the gel particles can be crushable gel beads 10 formed of an agar complex providing cosmetic, pharmaceutical, etc. delivery vehicles for topical delivery of biologically or cosmetically active agents. Preferred agar beads 10 are complexes of a continuous phase of agar gel 12 in a self-supporting solid or semi-solid form with a restraining polymer 14.
    Type: Grant
    Filed: November 12, 2001
    Date of Patent: September 27, 2011
    Assignee: Kobo Products, Inc.
    Inventors: Pascal E. Delrieu, Li Ding
  • Publication number: 20110229544
    Abstract: The present invention relates generally to the field of antibacterials and to the treatment, inhibition and prevention of disorders caused by bacteria. More particularly, this 5 invention concerns a method for inhibiting gram-positive bacteria with a composition comprising at least one non-phospholpid lipid vesicle.
    Type: Application
    Filed: November 20, 2009
    Publication date: September 22, 2011
    Applicant: VIROBLOCK S.A.
    Inventors: Thierry Pelet, Franck Matheux
  • Publication number: 20110207786
    Abstract: The present technology relates to biocidal compositions and methods that contain and utilize at least one biocidal agent and at least one potentiator system wherein the resultant combination has an enhanced biocidal efficacy. The present technology also discloses a rapid screening assay for determining biocidal compositions with enhanced efficacy, e.g., a microbial contact kill time of 5 minutes or less. Further, the present technology provides a method of determining biocidally effective concentrations of biocidal compositions comprising at least one biocidal agent and at least one potentiator system.
    Type: Application
    Filed: February 25, 2011
    Publication date: August 25, 2011
    Inventors: Molly Ryan Callahan, David Shelton
  • Patent number: 7999064
    Abstract: A multipurpose solution for contact lens care, comprising: an aqueous liquid medium; a quaternary ammonium polymer having an average molecular weight as determined by the proton NMR method of at least 28 k, and methods for making the same.
    Type: Grant
    Filed: April 23, 2009
    Date of Patent: August 16, 2011
    Assignee: Abbott Medical Optics Inc.
    Inventor: Zhi-Jian Yu
  • Patent number: 7999063
    Abstract: A multipurpose solution for contact lens care, comprising: an aqueous liquid medium; a quaternary ammonium polymer having an average molecular weight as determined by the proton NMR method of at least 22 k, and methods for making.
    Type: Grant
    Filed: April 23, 2009
    Date of Patent: August 16, 2011
    Assignee: Abbott Medical Optics Inc.
    Inventor: Zhi-Jian Yu
  • Publication number: 20110196383
    Abstract: A method and chemical composition for modifying and dissolving atherosclerotic plaques formed in a patient's blood vessels is provided. A chemical composition comprising one or more of an organic substance, an inorganic substance, and a bioactive substance is administered at sites of the plaques. The chemical composition comprises one or more of d-limonene, propylene glycol, octanoic acid, 2-octane, glycerine, acetylsalicylic acid, acetic acid, omega-3 fatty acids, ethanol, methanol, ezetimibe, rosuvastatin, resveratrol, lactic acid, gluconic acid, chloroform, carbon disulfide, dichloromethane, toluene, lauryldimethyl hydroxysultaine, and any combination thereof. The chemical composition enables modification of plaques by altering their composition. The modification comprises partial dissolution, complete dissolution, or elimination of the plaques, and makes the plaques amenable to different forms of plaque treatment. The modified plaques are eliminated from the patient's body.
    Type: Application
    Filed: April 15, 2011
    Publication date: August 11, 2011
    Inventors: Kusai Saadeldin Aziz, Gary Michael Saxton
  • Publication number: 20110189257
    Abstract: There are provided compositions and methods to aggregate mucus using a plurality of positively charged nanoparticles. There are also provided compositions and methods for inducing contraception in the subject.
    Type: Application
    Filed: February 2, 2011
    Publication date: August 4, 2011
    Inventors: Wei-Chun Chin, Eric Yi-Tong Chen
  • Patent number: 7985773
    Abstract: Antimicrobial compositions which can be used wherever disinfecting compositions are needed, such as in a hospital, healthcare industry, workplace, recreational facility, home or similar environment. The antimicrobial compositions are particularly useful as a topical application for a substrate, such as skin and can be used as a hand sanitizer or pre-surgical scrub. The compositions comprise a synergistic combination of a simple aliphatic alcohol and an activity enhancing substance, wherein the composition provides, heretofore unexpected, persistent activity against a broad range of microorganisms, including gram-negative organisms, while moisturizing the skin.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: July 26, 2011
    Assignee: American Sterilizer Company
    Inventors: Zachariah C. Greten, Nancy-Hope E. Kaiser, Daniel A. Klein
  • Publication number: 20110171158
    Abstract: A polymeric material, methods of making the polymeric material, articles that include the polymeric material, and compositions that contain the polymeric material are provided. The polymeric material has a plurality of different pendant groups that include a first pendant group containing a —COOH group or a salt thereof, a second pendant group containing a poly(alkylene oxide) group, a third pendant group containing a silicon-containing group, and a fourth pendant group containing a quaternary amino group. The polymeric material can be used, for example, to provide coatings that can be antifouling, antimicrobial, or both.
    Type: Application
    Filed: August 25, 2009
    Publication date: July 14, 2011
    Inventors: John J. Stofko, JR., Jeremy M. Yarwood
  • Patent number: 7977403
    Abstract: The present invention relates to compositions comprising silicone elastomers and antiseptics in homogeneous distribution, to processes for the preparation thereof and to uses thereof, for example, in medical articles.
    Type: Grant
    Filed: April 27, 2007
    Date of Patent: July 12, 2011
    Assignee: Bayer Innovation GmbH
    Inventors: Marc Lohrmann, Heinz Pudleiner, Joachim Hyner
  • Publication number: 20110166236
    Abstract: A cleaning and disinfecting composition comprises a long-chain alkyl polyamine, such as dodecyl dipropylene triamine; a long-chain quaternary ammonium salt, such as N,N-didecyl-N,N-dimethylammonium chloride; and a metal carbonate salt, such as potassium carbonate, all in aqueous solution. A sequestering agent, a long-chain alkyl polyethoxylate, an alkanolamine and an anti-corrosive agent may also be present. The composition has a pH of at least 11 when diluted to an in-use concentration, and may be used to clean and disinfect hard surfaces, such as medical, dental and surgical implements, walls, floors, sinks and hard furnishing surfaces, or soft surfaces such as bedding, upholstery or clothing. The composition is effective as a virucide, a sporicide, a bacteriocide, a fungicide, and against yeasts and moulds, without harming the substrate cleansed.
    Type: Application
    Filed: March 13, 2009
    Publication date: July 7, 2011
    Applicant: AMITY LIMITED
    Inventors: Mokhles Tangestani-Nejad, Ram Singh
  • Patent number: 7973081
    Abstract: Composition containing quaternary ammonium compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, the composition including at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions are also disclosed.
    Type: Grant
    Filed: July 27, 2007
    Date of Patent: July 5, 2011
    Assignee: Novagali Pharma SA
    Inventors: Laura Rabinovich-Guilatti, Gregory Lambert, Frederic Lallemand, Betty Philips
  • Publication number: 20110152204
    Abstract: Provided herein are methods of treating obesity and diabetes with labile bile acid sequestrants. An effective amount of a labile bile acid sequestrant may be orally administered to an obese or diabetic individual. A labile bile acid sequestrant provided herein may have a low affinity in the colon or rectum of a human for at least one bile acid or bile acid mimic that stimulates L-cells. A labile bile acid sequestrant may be a non-systemic labile bile acid sequestrant.
    Type: Application
    Filed: December 15, 2010
    Publication date: June 23, 2011
    Applicant: Satiogen Pharmaceuticals, Inc.
    Inventors: Bronislava GEDULIN, Howard E. Greene, JR.
  • Publication number: 20110150968
    Abstract: A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or to prevent/treat alcohol induced hangovers. A method for treating malnutrition and/or preventing and treating alcohol-induced hangovers using a dissolvable orally administered strip.
    Type: Application
    Filed: June 18, 2010
    Publication date: June 23, 2011
    Inventor: Alessandra Grassi
  • Publication number: 20110142899
    Abstract: SUMMARY The present invention refers to new active nanocomposite materials, comprising a matrix and additives. The present invention also describes a process for obtaining these nanocomposite materials and their use in various industry sectors.
    Type: Application
    Filed: June 25, 2009
    Publication date: June 16, 2011
    Applicant: NANOBIOMATTERS, S.L.
    Inventors: Jose Maria Lagaron Abello, Maria Antonieta Busolo Pons, Maria Eugenia Nunez Calzado
  • Publication number: 20110135702
    Abstract: A cleaning medium or formulation that contains a sporicidal composition is described. The composition includes about 0.1-20% weight/weight of a germinant agent, about 0.01-75% w/w of an antimicrobial agent, in terms of dry or wet total weight, and which is admixed with water to generate a solution with a pH of 3.5-9.5. The composition can help trigger the germination of spores, in particular C. difficile, and subsequently deactivate or kill the spores. A means of applying the cleaning formulation in a medium and process for cleaning are also described.
    Type: Application
    Filed: December 9, 2009
    Publication date: June 9, 2011
    Inventors: Douglas R. Hoffman, Aimin He, David W. Koenig, Andrea J. Smiltneek, DaeGun Kim, YoungSook Kim
  • Publication number: 20110136912
    Abstract: The present invention is directed to an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The emulsion also includes a mucoadhesive polymer that aid in delivering a lipid to the ocular surface.
    Type: Application
    Filed: December 2, 2010
    Publication date: June 9, 2011
    Inventors: Howard Allen Ketelson, David L. Meadows
  • Publication number: 20110124738
    Abstract: The present invention relates to a chromate-free composition, to the use thereof for corrosion protection, and to a corrosion protection coating for the inside surfaces of fuel tanks, wherein the composition comprises binding agents, hardening agents, corrosion inhibitors and quaternary ammonium compounds in a quantity of at least 0.1% by weight.
    Type: Application
    Filed: January 15, 2009
    Publication date: May 26, 2011
    Inventors: Sven Schroeder, Diana Becker, Jan Kuever, Andreas Rabenstein, Martin Kaune, Yvonne Wilke, Matthias Geistbeck, Carmen Gerlach, Ottmar Schramm, Tanja Pietzker